Er positive cells were thymic epithelial cells and thymocytes.
ER阳性细胞为胸腺上皮细胞和胸腺细胞。
Methods These three genes were quantified by real-time quantification polymerase chain reaction (PCR) in er positive and er negative breast cancer cell lines.
方法应用实时监测聚合酶链反应检测这三种受体基因在雌激素受体阳性和雌激素受体阴性乳腺癌细胞系中的表达。
Conclusions: This is the first report that clearly distinguishes between the prognostic and predictive importance of 17hsd1 and 17hsd2 in ER-positive breast cancer treated with or without tamoxifen.
结论：这是第一篇雌激素受体阳性乳腺癌患者使用和不使用三苯氧胺治疗，明确区分17hsd1和17hsd2表达量对预后和预测之间的重要性。
I do however think that an element of stress is a good thing and if used the right way can er actually be a positive thing.
不过我还是觉得压力是一件好事，如果能正确地利用压力，其实会产生积极的效果。
At 3 years, ER-positive patients achieved a DRFS of 97% and a significant absolute risk reduction of 11%.
在治疗的第3年，雌激素受体阳性患者获得97%的无远处复发生存率，绝对危险度大幅下降11%。
Conclusions Adjuvant chemotherapy containing paclitaxel can improve the disease-free survival of breast cancer with HER-2 positive, especially for the patients with er and pr negative.
结论含紫杉醇类药物进行术后辅助化疗能增加HER - 2阳性乳腺癌患者无病生存获益，尤其是对ER、PR均阴性且her - 2阳性者。
The experimental results observed in passively mode-locked Er-doped fiber laser with positive dispersion are analyzed theoretically.
对观察到的正色散腔被动锁模掺铒光纤激光器的实验现象进行了理论分析。
Objective to explore whether er level of breast cancer with a positive cancerous family history shows a higher level than the breast cancer of non cancerous family.
目的为了探讨癌家族史阳性乳腺癌妇女er水平是否高于非癌家族性乳腺癌者。
None of the specimens contained solely receptor negative tumor cells. In 2 ovarian borderline tumors, the ER and PR positive cells were observed in regions showing relatively benignity.
未见全部由受体阴性癌细胞构成的肿瘤，卵巢交界性肿瘤的ER、PR阳性细胞多位于相对良性区域。
Conclusions the prognosis of bilateral primary mammary cancer is decided by whether axilla lymph node has transferred, whether the tumor is big or small, and whether the er receptor is positive.
结论：双侧原发性乳腺癌的预后取决于腋窝淋巴结有无转移，肿瘤大小以及ER受体是否阳性。
Are most of the cases with unstable expression of er, either gains or losses, occurring in patients with HER2-positive primary tumors?
“她问道：”大多数ER不稳定表达的病例，或者获得或丢失，在HER 2阳性原发肿瘤病人也发生吗？
Results: the course of senile breast cancer was long, the positive rate of er level was high and its prognosis was good.
结果：老年期乳腺癌病程长，雌激素受体阳性率高，预后较好。
Results: 54 cases' er and 47 cases' PR were positive for both two methods.
结果：两种方法，ER全部阳性者为54例，PR全部阳性者为47例。
Operation in luteal phase benefits to breast cancer patients who were positive for ER or PR.
结论黄体期手术有利于激素依赖型乳腺癌患者预后。
The endocrine therapy should be based on er and pr expression and clinical parameters, which are benefit for the patients with postmenopausal and er and PR-positive and the premenopausal patients.
对选择内分泌治疗，应根据ER和PR的表达及临床参数，对绝经后患者术后er和PR阳性者及绝经前的患者有益。
In this study, we evaluated the role of SF3B1 and SF3B3, critical parts of the SF3b splicing complex, in ER-positive endocrine resistance.
本研究中，我们评估了SF3b剪接复合体的关键部分SF3B1和SF3B3在ER阳性内分泌耐药乳腺癌中的作用。
This is the first study to document the role of SF3B3 in endocrine resistance and prognosis in ER-positive breast cancer.
这是SF3B3在ER阳性乳腺癌内分泌耐药和预后中作用的首次研究报道。
Breast cancer can be broadly separated into hormone-responsive (ER-positive) and non-hormone-responsive (ER-negative) subtypes.
乳腺癌可以大致被分类为雌激素受体阳性与雌激素受体阴性两类。
This pap-er analyzes the problems from three aspects:At first, this paper research the value why the effectiveness of a contract is written in our positive law.
首先，第一部分为合同生效的价值解释，该部分是文章论述的前提，讨论了合同之所以产生效力的原因，即合同效力的正当性问题；
Tamoxifen has been shown to reduce the recurrence of ER-positive breast cancer when used after primary treatment.
在一期治疗之后服用，Tamoxifen可以降低雌激素阳性乳腺癌的复发。
These results suggest that AR could be an additional marker for endocrine responsiveness in ER-positive cancers and a candidate for therapeutic targeting of ER-negative tumors.
这些结果表明，AR可为预测ER阳性乳腺癌内分泌疗效的附加指标，以及ER阴性肿瘤靶向治疗的候选靶点。
These results suggest that AR could be an additional marker for endocrine responsiveness in ER-positive cancers and a candidate for therapeutic targeting of ER-negative tumors.
这些结果表明，AR可为预测ER阳性乳腺癌内分泌疗效的附加指标，以及ER阴性肿瘤靶向治疗的候选靶点。
应用推荐